Skip to content

Comparing postoperative recovery after vitrectomy using NSAID eyedrops versus steroid eyedrops

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518807-23-00
Enrollment
120
Registered
2025-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular hole, Vitreomacular traction syndrome, Macular pucker

Brief summary

Incidence of an increase of at least 10 mmHg in IOP compared to baseline measured at week 2 and week 8.

Detailed description

Amount and grading of macular oedema on OCT at month 2 and 6 after surgery: - Presence or absence of intra-retinal cysts - Ratio of (Pre-op subfoveal thickness – Post-op thickness) / Pre-op thickness, Amount of intra-ocular inflammation measured using laser flare photometry at day 3 (+/_ 2 days), week 2 and week 8.

Interventions

DRUGDicloabak 1 mg/ml oogdruppels
DRUGVolon A 40
DRUGKristallsuspension

Sponsors

UZ Leuven
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Incidence of an increase of at least 10 mmHg in IOP compared to baseline measured at week 2 and week 8.

Secondary

MeasureTime frame
Amount and grading of macular oedema on OCT at month 2 and 6 after surgery: - Presence or absence of intra-retinal cysts - Ratio of (Pre-op subfoveal thickness – Post-op thickness) / Pre-op thickness, Amount of intra-ocular inflammation measured using laser flare photometry at day 3 (+/_ 2 days), week 2 and week 8.

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026